Kim, Jung Kuk,Kim, Dae Jin,Heo, Yong Ho,Choi, In Young,Jung, Sung Youb,Kwon, Se Chang
申请号：
AU2015268183
公开号：
AU2015268183A1
申请日:
2015.05.29
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to a composition for preventing or treating diabetes, containing long-acting insulin analog and long-acting insulin secretion peptide conjugates, and a method for treating diabetes. More specifically, the composition can remarkably improve compliance by inhibiting weight gain caused by the administration of insulin, inhibiting emesis and nausea phenomena caused by the administration of an insulin secretion peptide and reducing the dose of insulin through the concomitant administration of the long-acting analog conjugate and the long-acting insulin secretion peptide conjugate. In addition, the present invention relates to: a pharmaceutical composition for alleviating the side effects of pancreatic beta cells in a patient with diabetes, containing a long-acting insulin analog conjugate and a long-acting insulin secretion peptide conjugate； and a method for alleviating the side effects of pancreatic beta cells in a patient with diabetes, comprising a step of administering the composition, wherein side effects, particularly those such as pancreatic beta cell dysfunction, pancreatic beta cell reduction, lipotoxicity and glucotoxicity, which are caused by the progression of diabetes, are alleviated.
